CANNAPHARMARX, INC.
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Country Alberta, Canada
Business Address 4439 TOWNSHIP RD 304, MOUNTAIN VIEW COUNTY, , T0M 0R0
Mailing Address 4439 TOWNSHIP RD 304, MOUNTAIN VIEW COUNTY, , T0M 0R0
Phone 949-652-6838
Fiscal Year End 1231
EIN 274635140
Financial Overview
FY2024
$3.69M
Net Income
-$19.81M
Stockholders' Equity
$2K
Cash & Equivalents
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | January 13, 2026 | View on SEC |
| 8-K Current report of material events | December 18, 2025 | View on SEC |
| 10-Q Quarterly financial report | November 14, 2025 | View on SEC |
| 8-K Current report of material events | October 10, 2025 | View on SEC |
| 10-Q Quarterly financial report | August 14, 2025 | View on SEC |
| 10-Q Quarterly financial report | May 16, 2025 | View on SEC |
| 8-K Current report of material events | May 6, 2025 | View on SEC |
| 10-K Annual financial report | April 10, 2025 | View on SEC |
| 3 Initial insider ownership report | April 10, 2025 | View on SEC |
| 3 Initial insider ownership report | April 10, 2025 | View on SEC |
Material Events
8-K Legal Issue December 18, 2025
High Impact
- The British Columbia Securities Commission (BCSC) officially lifted the cease trade order against CannaPharmaRX, Inc.
- This regulatory clearance is a crucial step towards the company's shares being able to trade again, potentially on the OTC Pink Sheets.
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.